A study comparing preoperative and postoperative chemoradiotherapy to surgery alone in patients with resectable esophageal squamous cell carcinoma found significant differences in overall survival and progression-free survival. Perioperative chemoradiotherapy maximizes long-term survival, but increases toxicity.
A new study published in the Journal of Thoracic Oncology found that sleeve lobectomy offers superior survival and better postoperative pulmonary function compared to pneumonectomy in selected patients. The study analyzed 210 lung cancer patients and reported lower mortality rates for those who underwent a sleeve lobectomy.
A study published in the World Journal of Gastroenterology found that hepatectomy is an effective treatment for caudate lobe HCC, with subsegmental location and liver cirrhosis affecting long-term survival. Extended hepatectomy was recommended to achieve adequate tumor margins and improve survival rates.
The median survival time for metastatic breast cancer patients increased steadily over 25 years, with improved outcomes for those with grade III tumours. Targeted therapies, particularly trastuzumab, have contributed to these advancements, offering new hope for patients with aggressive forms of the disease.
Patients with metastatic breast cancer expect to prolong life by at least a year over current therapies, whereas doctors consider four to six months of additional survival significant. Thorough discussion of treatment goals is essential for both groups.
The largest European study on socioeconomic status and breast cancer survival found that women from poorer backgrounds had worse outcomes, even after adjusting for tumor size and stage. Women from the poorest backgrounds were a fifth more likely to die within ten years of diagnosis than those from the wealthiest backgrounds.
Adding chemotherapy to surgery or surgery plus radiotherapy significantly improves survival rates for patients with operable non-small-cell lung cancer. The meta-analysis found a 4% increase in survival at 5 years, regardless of the type of chemotherapy used.
A nationwide cohort study found that cardiopulmonary resuscitation by bystanders significantly improves survival outcomes for children with cardiac arrests. The study suggests a double CPR training strategy to increase bystander participation.
A new study published in the Journal of the American Dietetic Association found a strong relationship between healthy eating and prolonged ovarian cancer survival. Higher consumption of fruits, vegetables, and healthier grains was associated with improved survival rates.
A systematic review of literature found that micrometastases in axillary lymph nodes are associated with reduced disease-free and overall survival in breast cancer patients. The study's findings suggest that even small metastatic lesions can have a significant impact on patient outcomes.
A study found that contralateral prophylactic mastectomy is associated with improved 5-year breast cancer-specific survival rates for younger women with early-stage, estrogen-receptor negative tumors. However, the benefit is small and does not apply to most women with breast cancer.
A study found that pretreatment SUVmax is a strong predictor of disease-specific survival, overall survival, and disease-free survival in head and neck squamous cell carcinoma patients. Higher SUV-LN was associated with distant metastasis, suggesting more aggressive treatment approaches may be needed.
Researchers found that ALDH-positive tumor cells have a worse prognosis and are more likely to proliferate and invade compared to ALDH-negative cells. ALDH-positive cells were detected in 90% of primary surgical specimens and were associated with shorter overall survival.
Research published in Journal of Thoracic Oncology investigates the effectiveness of surgery as a standalone treatment for stage I small cell lung cancer. The study found three- and five-year survival rates of 58.1% and 50.3%, respectively, for patients who underwent lobectomies without radiotherapy.
A new study published in The Lancet found that combination therapy does not improve overall or progression-free survival compared to single therapy for renal cell carcinoma. However, the combined regimen may still benefit a small number of patients by producing long remissions.
Patients who underwent peripheral blood stem cell transplantation (PBSC) had similar overall survival rates as those given bone marrow transplants, with no significant differences in mortality or late effects. However, subgroup analyses revealed improved leukaemia-free survival and overall survival for patients with acute leukaemias
Research shows that later birth years are associated with higher survival rates for children with congenital anomalies. Advances in treatments, surgical techniques, and prenatal diagnosis have contributed to this trend. The study analyzed data from the UK Northern Congenital Abnormality Survey and found varying survival rates for diffe...
The study analyzed data from 15 trials involving 3,452 women, finding that chemoradiotherapy improved survival rates compared to radiotherapy alone. This treatment also reduced the chance of cancer recurrence and spread.
Researchers classified tumors into three growth patterns: destructive, alveolar, and papillary, which were independent predictors for overall survival, disease-specific survival, and disease-free survival. Patients with an alveolar growth pattern had a significantly higher risk of poor prognosis and reduced survival rates.
Researchers have developed a new survival prediction equation for pulmonary arterial hypertension (PAH), improving upon an outdated NIH equation. The new formula shows vastly improved survival rates, highlighting the need for accurate hemodynamic assessment.
Patients with NSCLC and EGFR mutations showed significantly improved progression-free survival with gefitinib treatment. Gefitinib was also better tolerated than chemotherapy, with fewer severe adverse events.
Researchers found substantial racial and ethnic disparities in cancer survival, particularly in more treatable cancers like breast and prostate cancer. The study suggests that social disadvantage contributes to these disparities, highlighting the need for targeted health policies and interventions.
A recent study published in Mayo Clinic Proceedings found that young patients with primary myelofibrosis who received modern treatments lived longer than those diagnosed earlier, suggesting a beneficial effect from modern therapeutic approaches.
Research analyzed over 100,000 patients with stage IV non-small cell lung cancer and found a modest but statistically significant improvement in one-year and two-year overall survival rates from 13.2% to 19.4% and 4.5% to 7.8%, respectively.
Researchers analyzed CT scans of 50 surgical patients with metastatic colorectal cancer to predict overall survival. The findings showed that morphologic changes on CT images correlated with pathologic response and improved survival.
A study found that morphologic changes on CT scans after bevacizumab-containing chemotherapy can predict overall survival in patients with stage IV colorectal cancer. The changes, including tumor size reduction and unique structural alterations, were strongly correlated with pathologic response and improved survival.
Patients who received IV drug administration during cardiopulmonary resuscitation had higher short-term survival rates, but no significant improvement in long-term survival compared to those without IV drug administration. CPR quality was similar between the two groups.
African-Americans have lower survival rates than whites after surgery for colon cancer; the study suggests genetic variation, tumor characteristics, access to healthcare, and other factors may be involved. Obesity was found to be protective in patients with advanced-stage disease, contradicting earlier assumptions.
A new study published in the American Journal of Roentgenology found that combining triple-drug TACE with a liver transplant significantly increased long-term survival rates for patients with unresectable liver cancer. The median survival time for patients who underwent the procedure was over 112 months.
Continuous chest compression-CPR has been shown to improve cardiac arrest survival in Arizona, with a 32% survival rate compared to 6% for standard CPR. This study found that bystanders can save more lives by performing chest compressions only instead of mouth-to-mouth CPR.
A new study suggests that progression-free survival (PFS) is a reasonable primary endpoint for clinical trials of metastatic cancer when the median survival post-progression (SPP) is less than 6 months. However, PFS benefit does not always translate to overall survival (OS) benefit in cases where SPP is longer than 12 months.
Adding cetuximab to radiation therapy improves survival rates in patients with locally advanced head and neck cancer, with benefits persisting for up to 5 years. Patients who develop a prominent rash after treatment show significantly improved overall survival compared to those without the rash.
A study models a 100 patient dialysis center and a program with 7,500 hemodialysis patients, finding that improved survival increases costs by $5 million over 10 years and $400 million over the same period. Research into less costly treatments could help address these concerns.
A recent study published in the American Society of Nephrology's Annual Meeting and Scientific Exposition found that kidney transplant survival rates vary by donor race, with non-black recipients experiencing lower survival rates when transplanted with black donors.
Researchers found that Barrett's esophagus patients have comparable survival rates to the general population, with a 10-year overall survival rate of 68%. Esophageal cancer was not significantly more common among these patients.
A phase 2 study found that adding imatinib mesylate to regular chemotherapy increased three-year survival rates for children with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) from 30-35% to 87%. The drug was well-tolerated and showed no significant side effects.
Researchers at the Thomas E. Starzl Transplantation Institute found that survival rates for intestinal and multivisceral transplants increased with innovative surgical techniques, novel immunosuppressive protocols, and better post-operative management. The five-year survival rate rose to 68 percent, similar to other abdominal and thora...
A multicenter clinical study found that maximizing chest compression time during CPR substantially improves survival rates. Interrupting chest compressions has a detrimental effect on patient survival, and researchers recommend relatively simple changes to CPR training and practice.
Women with metastatic colorectal cancer tend to live longer than men, with those under 45 years old experiencing the greatest survival advantage. However, this benefit disappears with age, suggesting that hormones may be contributing to better outcomes in younger patients.
A randomized phase III study found that pemetrexed significantly improved progression-free survival (4.3 months vs 2.6 months) and overall survival (13.4 months vs 10.6 months) compared to placebo in patients with advanced non-squamous NSCLC who did not progress after initial platinum-based chemotherapy.
A phase III randomised controlled trial found that dose-dense weekly paclitaxel plus carboplatin improved survival in women with advanced epithelial ovarian cancer, with a median progression-free survival of 28 months compared to 17 months. Overall survival at 3 years was also higher in the dose-dense regimen group.
A study published in JAMA Network found that black patients who experience in-hospital cardiac arrest are less likely to survive, with racial disparities largely attributed to the hospital's quality of care. The researchers discovered that black patients were more likely to receive treatment at hospitals with poorer outcomes.
A study found that black patients have lower survival rates after in-hospital cardiac arrests compared to white patients. The racial difference was largely associated with the quality of hospitals where black patients received care.
A pooled analysis of six clinical trials found that pretreatment quality of life can predict overall survival in patients with advanced stage NSCLC. Patients with low self-assessed quality of life have twice the risk of death as those with high scores.
A Phase II study shows Avastin significantly increases response rates, progression-free survival times and survival rates in patients with recurrent glioblastoma. The treatment was found to be effective both alone and in combination with chemotherapy, improving patient outcomes and quality of life.
Researchers identified Hexokinase 2 as a key player in glucose metabolism and cell survival for breast cancer patients with brain metastases. Patients with high levels of Hexokinase 2 expression in their brain metastasis had significantly lower median survival rates compared to those with lower expression.
A study published in World Journal of Gastroenterology found that a large number of dissected lymph nodes in D2 dissection improves long-term survival and reduces recurrence rate for patients with node-negative gastric cancer. The number of resected lymph nodes is a key prognostic indicator, and increasing it leads to better survival o...
A new analysis reveals that adolescents and young adults with blood-related cancers have better long-term survival rates than those diagnosed in the 1980s. However, survival rates in this age group are still lower than those seen in younger children and some older adults.
A new study found that unmarried cancer patients who are separated at diagnosis have poorer survival rates compared to widowed, divorced, and never married patients. The researchers suggest that the stress of separation may compromise an individual's immune system and lead to a greater susceptibility to cancer.
Researchers have discovered genetic biomarkers relevant to CRC, allowing for personalized medication and improved survival rates. The integration of conventional agents with novel targeted therapies has led to median overall survival exceeding two years in metastatic CRC.
A new study from the University of Michigan Comprehensive Cancer Center found that hospitals treating more black cancer patients have lower survival rates for breast and colon cancer, regardless of race. The researchers suggest that factors such as hospital resources and quality of care are key contributors to these disparities.
A study published in Archives of Otolaryngology–Head & Neck Surgery found that post-treatment pain in head and neck cancer patients is associated with a lower five-year survival rate and increased risk of recurrence. Pain was also linked to age, general health conditions, and treatment modality.
Oral sodium clodronate reduces death by 23% and increases overall survival to 30% at 5 years for patients with advanced prostate cancer. However, in men with localized disease, clodronate shows no improvement in overall survival.
A groundbreaking study suggests that HPV improves survival in squamous cell carcinoma of the head and neck, but African Americans had fewer instances of infection, leading to worse outcomes. The research found a significant difference in median overall survival between HPV-positive and negative patients.
New research reveals that African American patients with gastrointestinal stromal tumors (GIST) are experiencing improved survival rates, thanks to better diagnosis and surgical treatment. Prior to 2000, racial disparities in survival rates were significant, but recent improvements have closed the gap.
Researchers found African Americans have lower survival rates for breast, prostate, and ovarian cancers due to biological factors, not socioeconomic ones. The study of 19,457 patients showed 49% more likelihood of death from early-stage breast cancer among African Americans.
A study of nearly 20,000 patient records found that African-American breast, ovarian, and prostate cancer patients die earlier than others with similar treatment, suggesting biological or host genetic factors as the cause. The survival gap persists even after controlling for socioeconomic factors.
A Swedish study found improved long-term survival rates among patients with intact abdominal aortic aneurysms who underwent surgical repair between 1987 and 2005. Patients in their 80s and males experienced higher relative five-year survival rates, likely due to atherosclerosis, whereas advances in postoperative care and endovascular a...
Researchers have identified key signals supporting long-term survival of breast cancer cells after they spread to the bone marrow. The study found that activity of a cancer-related enzyme called Src is associated with late-onset bone metastasis and promotes cell survival.
Survival rates for elderly patients receiving hospital CPR remained steady from 1992 to 2005, with no improvement in outcomes. Researchers found that elderly black patients were less likely to survive CPR due to factors like lower post-CPR survival rates and more requests for resuscitation.